Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed FCF Margin for 2 consecutive years, with 6015.54% as the latest value for Q1 2024.

  • For Q1 2024, FCF Margin changed N/A year-over-year to 6015.54%; the TTM value through Dec 2024 reached 22180.88%, changed N/A, while the annual FY2024 figure was 22180.88%, 2202953.0% down from the prior year.
  • FCF Margin hit 6015.54% in Q1 2024 for Artiva Biotherapeutics, down from 481.32% in the prior quarter.
  • Across five years, FCF Margin topped out at 40.99% in Q3 2023 and bottomed at 6015.54% in Q1 2024.